EMA Weighs Rules Around Protection of Trade Secrets in Clinical Trials

Drug Industry Daily
A A
The European Medicines Agency appears to be backing off promises to protect industry trade secrets in its new clinical trials database, and is developing scenarios under which it would release commercially confidential information.

To View This Article:

Login

Subscribe To Drug Industry Daily